Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced that the U.S. Food and Drug Administration has granted tentative approval for the Company’s Abbreviated New Drug Application (ANDA) to market its generic version of Eli Lilly and Co’s cancer treatment Gemzar? (Gemcitabine) for injection, 200 mg base/vial.
Boehringer Ingelheim GmbH announced that it has initiated and begun enrollment of patients in the ArTEN trial, which will compare the efficacy and safety of Viramune? (nevirapine), a non-nucleoside reverse transcriptase inhibitor (NNRTI), dosed once daily (QD) or twice daily (BID), versus atazanavir/ritonavir, a once-daily dosed protease inhibitor (PI).
Roche announced that the U.S. Food & Drug Administration (FDA) has approved its new HIV-1 test for diagnostic use in the United States. The highly accurate Cobas AmpliPrep/Cobas TaqMan HIV-1 Test is the first fully automated HIV-1 diagnostic tool using real-time PCR technology in the US.
Health care providers and medical marijuana patients and supporters reacted to Senate defeat of medical marijuana legislation by vowing to renew the fight. SB 650, sponsored by Sen. John Cullerton (D-Chicago), failed by a vote of 22-29, with four voting “present.”
Commenting on the BMA’s report, Nigel Edwards, director of policy at the NHS Confederation which represents over 90 per cent of NHS organisations, said:
The Honourable Tony Clement, Minister of Health, congratulated three recipients of the Award of Excellence in Nursing for nurses working in First Nations and Inuit communities. The ceremony, held during National Nursing Week, took place at the Government Conference Centre in Ottawa.
PriCara?, Unit of Ortho-McNeil, Inc., announced that the Southern District Court of New York ruled that the patent for ACIPHEX? (rabeprazole sodium 20 mg tablets) is enforceable. PriCara and Eisai Inc. co-promote ACIPHEX in the United States.
The results of the 2006 National Sentinel Audit for Stroke show that patients are spending more of their time on stroke units, but there are still unacceptable waits for brain scans and starting treatment.
While one in four cancer survivors participates in a support group after diagnosis, use of support groups varies considerably by cancer type, and few survivors receive referrals to such programs from their physicians, according to a new study.
Fatigue is one of the most common and distressing symptoms cancer patients experience during chemotherapy and radiation treatment, but it’s difficult for health care professionals to accurately assess its severity.